Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders
March 21 2017 - 8:15AM
Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the
“Company”), a clinical-stage biopharmaceutical firm engaged in the
development of effective immunotherapies for cancer and stem cell
therapies for degenerative diseases, today announced that the
Annual Meeting of Stockholders will be held on Friday, April 28,
2017. The meeting will be held at the Company’s office at 19925
Stevens Creek Blvd., Suite 100, Cupertino, California 95014 at 9:00
a.m. PDT. Stockholders of record as of March 10, 2017, the record
date for the meeting, are authorized and asked to vote in the
manner directed in the proxy materials.
A stockholder, once having received his/her
proxy notice and access card, may view the proxy statement and
related materials online or request a printed copy
at www.iproxydirect.com/CBMG. Stockholders may vote online, by
mail or by phone, according to the instructions on the proxy, no
later than 11:59 p.m., Thursday, April 27, 2017, EDT. If your
shares are held in the name of a bank, broker or other nominee,
please check with your bank, broker or nominee and follow the
voting instructions it provides. Please send an email
to sarah.kelly@cellbiomedgroup.com if you have questions
about the Annual Meeting or have not received your proxy notice
card by post or by email.
About Cellular Biomedicine Group (CBMG)
Cellular Biomedicine Group, Inc. develops proprietary cell
therapies for the treatment of cancer and degenerative diseases. We
conduct immuno-oncology and stem cell clinical trials in China
using products from our integrated GMP laboratory. Our GMP
facilities in China, consisting of twelve independent cell
production lines, are designed and managed according to both China
and U.S. GMP standards. To learn more about CBMG, please visit
www.cellbiomedgroup.com.
Contacts:
Sarah Kelly
Director of Corporate Communications, CBMG
+1 408-973-7884
sarah.kelly@cellbiomedgroup.com
Vivian Chen
Managing Director Investor Relations, Citigate Dewe Rogerson
+1 347 481-3711
vivian.chen@citigatedr.com
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Apr 2023 to Apr 2024